Clinical Application of Allogeneic Peripheral Blood Stem Cells Transplantation

Overview

Journal Ann Hematol

Specialty Hematology

Date 1995 Dec 1

PMID 8534756

Authors

J Tanaka

M Kasai

M Imamura

M Asaka

Affiliations

Soon will be listed here.

Abstract

Recombinant human granulocyte colony-stimulating factor (rhG-CSF)-mobilized peripheral blood stem cells (PBSC) are now widely used for autologous transplantation to provide hematopoietic stem cells after intensive chemoradiotherapy. However, PBSC which contain a large number of T cells represent a potential risk for graft-versus-host disease (GVHD) in allogeneic (allo) transplantation. There are about 50 case reports of clinical trials of rhG-CSF-mobilized allo PBSC transplantation (PBSCT) with relatively rapid hematological recovery, without severe acute GVHD except in a few cases. Therefore, the risk of inducing severe acute GVHD is not as high as was expected when allo PBSCT began. However, whether allo PBSCT will increase the risk of chronic GVHD is not clear, because the period of observation has been too short. Also, it will be of interest to determine the clinical effect of allo PBSCT on relapse of hematological malignancy post-transplant. Whether allo PBSCT will increase life-threatening acute and chronic GVHD, and whether PBSC allografting will result in permanent hematological and immunological reconstitution has to be determined by prospective randomized clinical trials.

References

SUZUE T, Kawano Y, Takaue Y, Kuroda Y . Cell processing protocol for allogeneic peripheral blood stem cells mobilized by granulocyte colony-stimulating factor. Exp Hematol. 1994; 22(9):888-92. View

Theobald M, Nierle T, Bunjes D, Arnold R, Heimpel H . Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. N Engl J Med. 1992; 327(23):1613-7. DOI: 10.1056/NEJM199212033272301. View

de Revel T, Appelbaum F, Storb R, Schuening F, Nash R, Deeg J . Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood. 1994; 83(12):3795-9. View

Tanaka J, Imamura M, Kasai M, Kobayashi S, Hashino S, Kobayashi H . Cytokine gene expression in the mixed lymphocyte culture in allogenic bone marrow transplants as a predictive method for transplantation-related complications. Br J Haematol. 1994; 87(2):415-8. DOI: 10.1111/j.1365-2141.1994.tb04935.x. View

Russell N, Hunter A . Peripheral blood stem cells for allogeneic transplantation. Bone Marrow Transplant. 1994; 13(4):353-5. View

Tjonnfjord G, Steen R, Evensen S, Thorsby E, Egeland T . Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood. 1994; 84(8):2795-801. View

Richman C, WEINER R, Yankee R . Increase in circulating stem cells following chemotherapy in man. Blood. 1976; 47(6):1031-9. View

Schiller G, Vescio R, Freytes C, Spitzer G, Sahebi F, Lee M . Transplantation of CD34+ peripheral blood progenitor cells after high-dose chemotherapy for patients with advanced multiple myeloma. Blood. 1995; 86(1):390-7. View

Johnson B, Truitt R . Delayed infusion of immunocompetent donor cells after bone marrow transplantation breaks graft-host tolerance allows for persistent antileukemic reactivity without severe graft-versus-host disease. Blood. 1995; 85(11):3302-12. View

10.

Lane T, Law P, Maruyama M, Young D, Burgess J, Mullen M . Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood. 1995; 85(1):275-82. View

11.

Sheridan W, Begley C, Juttner C, Szer J, To L, Maher D . Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet. 1992; 339(8794):640-4. DOI: 10.1016/0140-6736(92)90795-5. View

12.

Neben S, Marcus K, Mauch P . Mobilization of hematopoietic stem and progenitor cell subpopulations from the marrow to the blood of mice following cyclophosphamide and/or granulocyte colony-stimulating factor. Blood. 1993; 81(7):1960-7. View

13.

Dreger P, Suttorp M, Haferlach T, Loffler H, Schmitz N, Schroyens W . Allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for treatment of engraftment failure after bone marrow transplantation. Blood. 1993; 81(5):1404-7. View

14.

Wagner J, Donnenberg A, Noga S, Cremo C, Gao I, Yin H . Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial. Blood. 1988; 72(4):1168-76. View

15.

Negrin R, Still B, Schriber J, Chao N, Long G, Hoyle C . Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. Blood. 1995; 85(11):3334-41. View

16.

Tanaka J, Imamura M, Kasai M, Masauzi N, Watanabe M, Matsuura A . Rapid analysis of tumor necrosis factor-alpha mRNA expression during venoocclusive disease of the liver after allogeneic bone marrow transplantation. Transplantation. 1993; 55(2):430-2. View

17.

Tanaka J, Imamura M, Kasai M, Masauzi N, Matsuura A, Ohizumi H . Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation. Br J Haematol. 1993; 85(3):558-65. DOI: 10.1111/j.1365-2141.1993.tb03348.x. View

18.

Antin J, Ferrara J . Cytokine dysregulation and acute graft-versus-host disease. Blood. 1992; 80(12):2964-8. View

19.

Gianni A, Siena S, Bregni M, Tarella C, Stern A, Pileri A . Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet. 1989; 2(8663):580-5. DOI: 10.1016/s0140-6736(89)90711-3. View

20.

Dreger P, Haferlach T, Eckstein V, Jacobs S, Suttorp M, Loffler H . G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft. Br J Haematol. 1994; 87(3):609-13. DOI: 10.1111/j.1365-2141.1994.tb08321.x. View